COVID-19 admission risk tools should include multiethnic age structures, multimorbidity and deprivation metrics for air pollution, household overcrowding, housing quality and adult skills.
Age Distribution
Age Factors
Aged
Air Pollution
/ analysis
Benchmarking
/ methods
COVID-19
/ ethnology
Comorbidity
Crowding
Ethnicity
Female
Follow-Up Studies
Housing
/ standards
Humans
Male
Middle Aged
Multimorbidity
Patient Admission
Risk Assessment
/ methods
Risk Factors
SARS-CoV-2
United Kingdom
/ epidemiology
COVID-19
pneumonia
respiratory infection
viral infection
Journal
BMJ open respiratory research
ISSN: 2052-4439
Titre abrégé: BMJ Open Respir Res
Pays: England
ID NLM: 101638061
Informations de publication
Date de publication:
08 2021
08 2021
Historique:
received:
06
04
2021
accepted:
10
07
2021
entrez:
10
8
2021
pubmed:
11
8
2021
medline:
19
8
2021
Statut:
ppublish
Résumé
Ethnic minorities account for 34% of critically ill patients with COVID-19 despite constituting 14% of the UK population. Internationally, researchers have called for studies to understand deterioration risk factors to inform clinical risk tool development. Multicentre cohort study of hospitalised patients with COVID-19 (n=3671) exploring determinants of health, including Index of Multiple Deprivation (IMD) subdomains, as risk factors for presentation, deterioration and mortality by ethnicity. Receiver operator characteristics were plotted for CURB65 and ISARIC4C by ethnicity and area under the curve (AUC) calculated. Ethnic minorities were hospitalised with higher Charlson Comorbidity Scores than age, sex and deprivation matched controls and from the most deprived quintile of at least one IMD subdomain: indoor living environment (LE), outdoor LE, adult skills, wider barriers to housing and services. Admission from the most deprived quintile of these deprivation forms was associated with multilobar pneumonia on presentation and ICU admission. AUC did not exceed 0.7 for CURB65 or ISARIC4C among any ethnicity except ISARIC4C among Indian patients (0.83, 95% CI 0.73 to 0.93). Ethnic minorities presenting with pneumonia and low CURB65 (0-1) had higher mortality than White patients (22.6% vs 9.4%; p<0.001); Africans were at highest risk (38.5%; p=0.006), followed by Caribbean (26.7%; p=0.008), Indian (23.1%; p=0.007) and Pakistani (21.2%; p=0.004). Ethnic minorities exhibit higher multimorbidity despite younger age structures and disproportionate exposure to unscored risk factors including obesity and deprivation. Household overcrowding, air pollution, housing quality and adult skills deprivation are associated with multilobar pneumonia on presentation and ICU admission which are mortality risk factors. Risk tools need to reflect risks predominantly affecting ethnic minorities.
Sections du résumé
BACKGROUND
Ethnic minorities account for 34% of critically ill patients with COVID-19 despite constituting 14% of the UK population. Internationally, researchers have called for studies to understand deterioration risk factors to inform clinical risk tool development.
METHODS
Multicentre cohort study of hospitalised patients with COVID-19 (n=3671) exploring determinants of health, including Index of Multiple Deprivation (IMD) subdomains, as risk factors for presentation, deterioration and mortality by ethnicity. Receiver operator characteristics were plotted for CURB65 and ISARIC4C by ethnicity and area under the curve (AUC) calculated.
RESULTS
Ethnic minorities were hospitalised with higher Charlson Comorbidity Scores than age, sex and deprivation matched controls and from the most deprived quintile of at least one IMD subdomain: indoor living environment (LE), outdoor LE, adult skills, wider barriers to housing and services. Admission from the most deprived quintile of these deprivation forms was associated with multilobar pneumonia on presentation and ICU admission. AUC did not exceed 0.7 for CURB65 or ISARIC4C among any ethnicity except ISARIC4C among Indian patients (0.83, 95% CI 0.73 to 0.93). Ethnic minorities presenting with pneumonia and low CURB65 (0-1) had higher mortality than White patients (22.6% vs 9.4%; p<0.001); Africans were at highest risk (38.5%; p=0.006), followed by Caribbean (26.7%; p=0.008), Indian (23.1%; p=0.007) and Pakistani (21.2%; p=0.004).
CONCLUSIONS
Ethnic minorities exhibit higher multimorbidity despite younger age structures and disproportionate exposure to unscored risk factors including obesity and deprivation. Household overcrowding, air pollution, housing quality and adult skills deprivation are associated with multilobar pneumonia on presentation and ICU admission which are mortality risk factors. Risk tools need to reflect risks predominantly affecting ethnic minorities.
Identifiants
pubmed: 34373239
pii: 8/1/e000951
doi: 10.1136/bmjresp-2021-000951
pmc: PMC8354812
pii:
doi:
Types de publication
Journal Article
Multicenter Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Lancet Respir Med. 2021 Apr;9(4):349-359
pubmed: 33444539
Clin Microbiol Rev. 2003 Jan;16(1):144-72
pubmed: 12525430
Environ Sci Pollut Res Int. 2019 Feb;26(4):3208-3225
pubmed: 30569352
BMJ. 2020 Apr 7;369:m1328
pubmed: 32265220
BMJ. 2020 Oct 20;371:m3731
pubmed: 33082154
Infect Dis (Lond). 2021 Aug;53(8):640-642
pubmed: 33691577
Lancet Psychiatry. 2020 Jul;7(7):e40
pubmed: 32563315
Cardiovasc Res. 2020 Dec 1;116(14):2247-2253
pubmed: 33236040
BMJ. 2020 Jan 6;368:l6964
pubmed: 31907164
BMJ. 2020 Sep 9;370:m3339
pubmed: 32907855
BMC Public Health. 2004 Jun 03;4:19
pubmed: 15176983
BMC Cardiovasc Disord. 2019 Aug 19;19(1):200
pubmed: 31426745
Environ Pollut. 2015 Mar;198:201-10
pubmed: 25622242
J Infect. 2020 Sep;81(3):e96-e98
pubmed: 32474039
BMC Med. 2020 Apr 10;18(1):78
pubmed: 32272927
Thorax. 2003 May;58(5):377-82
pubmed: 12728155
BMJ. 2017 Jan 27;356:i6718
pubmed: 31055306
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
Lancet Infect Dis. 2018 Aug;18(8):e217-e227
pubmed: 29680581
BMJ. 2016 Oct 24;355:i4512
pubmed: 31055337
Eur Respir J. 2020 Dec 24;56(6):
pubmed: 32978307
J R Soc Med. 2021 Apr;114(4):182-211
pubmed: 33759630
J Infect Dis. 2008 Mar 15;197(6):812-6
pubmed: 18269318
J Public Health (Oxf). 2020 Aug 18;42(3):451-460
pubmed: 32556213
Am J Respir Crit Care Med. 2010 Jan 1;181(1):5-6
pubmed: 20026751